PMID- 23860206 OWN - NLM STAT- MEDLINE DCOM- 20140211 LR - 20211021 IS - 1422-0067 (Print) IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 14 IP - 7 DP - 2013 Jul 15 TI - Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats. PG - 14700-11 LID - 10.3390/ijms140714700 [doi] AB - Metabolic syndrome is associated with an increased risk of colorectal cancer. This study investigated the impact of hypertension, a component of metabolic syndrome, on azoxymethane (AOM)-induced colorectal carcinogenesis using SHRSP/Izm (SHRSP) non-diabetic/hypertensive rats and SHRSP.Z-Leprfa/IzmDmcr (SHRSP-ZF) diabetic/hypertensive rats. Male 6-week-old SHRSP, SHRSP-ZF, and control non-diabetic/normotensive Wister Kyoto/Izm (WKY) rats were given 2 weekly intraperitoneal injections of AOM (20 mg/kg body weight). Two weeks after the last injection of AOM, the SHRSP and SHRSP-ZF rats became hypertensive compared to the control WKY rats. Serum levels of angiotensin-II, the active product of the renin-angiotensin system, were elevated in both SHRSP and SHRSP-ZF rats, but only the SHRSP-ZF rats developed insulin resistance, dyslipidemia, and hyperleptinemia and exhibited an increase in adipose tissue. The development of AOM-induced colonic preneoplastic lesions and aberrant crypts foci, was significantly accelerated in both SHRSP and SHRSP-ZF hypertensive rats, compared to WKY normotensive rats. Furthermore, induction of oxidative stress and exacerbation of inflammation were observed in the colonic mucosa and systemically in SHRSP and SHRSP-ZF rats. Our findings suggest that hypertension plays a role in the early stage of colorectal carcinogenesis by inducing oxidative stress and chronic inflammation, which might be associated with activation of the renin-angiotensin system. FAU - Kochi, Takahiro AU - Kochi T AD - Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. FAU - Shimizu, Masahito AU - Shimizu M FAU - Ohno, Tomohiko AU - Ohno T FAU - Baba, Atsushi AU - Baba A FAU - Sumi, Takafumi AU - Sumi T FAU - Kubota, Masaya AU - Kubota M FAU - Shirakami, Yohei AU - Shirakami Y FAU - Tsurumi, Hisashi AU - Tsurumi H FAU - Tanaka, Takuji AU - Tanaka T FAU - Moriwaki, Hisataka AU - Moriwaki H LA - eng PT - Journal Article DEP - 20130715 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Carcinogens) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-6) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 11128-99-7 (Angiotensin II) RN - EC 1.11.1.6 (Catalase) RN - EC 1.11.1.9 (Glutathione Peroxidase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.99.1 (Cyclooxygenase 2) RN - MO0N1J0SEN (Azoxymethane) SB - IM MH - Adipose Tissue/metabolism MH - Angiotensin II/blood MH - Animals MH - Azoxymethane/*toxicity MH - Carcinogens/*toxicity MH - Catalase/genetics/metabolism MH - Chemokine CCL2/genetics/metabolism MH - Colorectal Neoplasms/*pathology MH - Cyclooxygenase 2/blood MH - Glutathione Peroxidase/genetics/metabolism MH - Hypertension/*pathology MH - Insulin Resistance MH - Interleukin-6/blood MH - Intestinal Mucosa/metabolism MH - Male MH - Nitric Oxide Synthase Type II/genetics/metabolism MH - Oxidative Stress/*drug effects MH - Precancerous Conditions MH - RNA, Messenger/metabolism MH - Rats MH - Rats, Inbred SHR MH - Rats, Inbred WKY MH - Rats, Zucker MH - Tumor Necrosis Factor-alpha/blood/genetics/metabolism PMC - PMC3742268 EDAT- 2013/07/19 06:00 MHDA- 2014/02/12 06:00 PMCR- 2013/07/01 CRDT- 2013/07/18 06:00 PHST- 2013/05/02 00:00 [received] PHST- 2013/06/25 00:00 [revised] PHST- 2013/06/27 00:00 [accepted] PHST- 2013/07/18 06:00 [entrez] PHST- 2013/07/19 06:00 [pubmed] PHST- 2014/02/12 06:00 [medline] PHST- 2013/07/01 00:00 [pmc-release] AID - ijms140714700 [pii] AID - ijms-14-14700 [pii] AID - 10.3390/ijms140714700 [doi] PST - epublish SO - Int J Mol Sci. 2013 Jul 15;14(7):14700-11. doi: 10.3390/ijms140714700.